Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: A review of recent research developments

Trends in Food Science and Technology

Volumn 54, Issue , 2016, Pages 114-126

  Arora, Divya ^a,b   Jaglan, Sundeep ^a,b  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Cancer; Delivery systems; Micelles; Nanoparticles; Nutraceuticals

Indexed keywords

BIOCHEMISTRY; CONTROLLED DRUG DELIVERY; ENZYME INHIBITION; MICELLES; NANOPARTICLES; SIGNAL TRANSDUCTION; TARGETED DRUG DELIVERY;

CANCER; CHEMOTHERAPEUTIC DRUGS; CLINICAL INVESTIGATION; DELIVERY SYSTEMS; NUTRACEUTICAL PRODUCTS; NUTRACEUTICALS; ORAL BIOAVAILABILITIES; SIGNAL TRANSDUCTION PATHWAYS;

DISEASES;

EID: 84974555444     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2016.06.003     Document Type: Review

References (124)

1. Ahmad A., Ginnebaugh K.R., Li Y., Padhye S.B., Sarkar F.H. Molecular targets of naturopathy in cancer research: bridge to modern medicine. Nutrients 2015, 7:321-334.
2. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nature Reviews Cancer 2002, 2:750-763.
3. Anselmo A.C., Mitragotri S. A review of clinical translation of inorganic nanoparticles. The AAPS Journal 2015, 17:1041-1054.
4. Arora D., Sharma N., Sharma V., Abrol V., Shankar R., Jaglan S. An update on polysaccharide-based nanomaterials for antimicrobial applications. Applied Microbiology and Biotechnology 2016, 100:2603-2615.
5. Bethune S.J., Schultheiss N., Henck J.-O. Improving the poor aqueous solubility of nutraceutical compound pterostilbene through cocrystal formation. Crystal Growth & Design 2011, 11:2817-2823.
6. Bhattacharya S., Ahir M., Patra P., Mukherjee S., Ghosh S., Mazumdar M., et al. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Biomaterials 2015, 51:91-107.
7. Bianco A., Kostarelos K., Prato M. Making carbon nanotubes biocompatible and biodegradable. Chemical Communications 2011, 47:10182-10188.
8. Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 2015, 33:941-951.
9. Bothiraja C., Kapare H.S., Pawar A.P., Shaikh K.S. Development of plumbagin-loaded phospholipid-Tween(R) 80 mixed micelles: Formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing. Ther Deliv 2013, 4:1247-1259.
10. Brower V. Nutraceuticals: Poised for a healthy slice of the healthcare market?. Nature Biotechnology 1998, 16:728-732.
11. Cao Y., Gao M., Chen C., Fan A., Zhang J., Kong D., et al. Triggered-release polymeric conjugate micelles for on-demand intracellular drug delivery. Nanotechnology 2015, 26:115101.
12. Chang M., Zhang F., Wei T., Zuo T., Guan Y., Lin G., et al. Smart linkers in polymer-drug conjugates for tumor-targeted delivery. Journal of Drug Targeting 2015, 1-17.
13. Chen R., Wang S., Zhang J., Chen M., Wang Y. Aloe-emodin loaded solid lipid nanoparticles: Formulation design and in vitro anti-cancer study. Drug Delivery 2015, 22:666-674.
14. Collnot E.-M., Baldes C., Schaefer U.F., Edgar K.J., Wempe M.F., Lehr C.-M. Vitamin E TPGS P-glycoprotein inhibition mechanism: Influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Molecular Pharmaceutics 2010, 7:642-651.
15. Conklin K.A. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integrative Cancer Therapies 2005, 4:110-130.
16. Cui H., Zhang A.J., Chen M., Liu J.J. ABC transporter inhibitors in reversing multidrug resistance to chemotherapy. Current Drug Targets 2015, 16:1356-1371.
17. Dai L., Li C.-X., Liu K.-F., Su H.-J., Chen B.-Q., Zhang G.-F., et al. Self-assembled serum albumin-poly (l-lactic acid) nanoparticles: A novel nanoparticle platform for drug delivery in cancer. RSC Advances 2015, 5:15612-15620.
18. Debnath S., Saloum D., Dolai S., Sun C., Averick S., Raja K., et al. Dendrimer-curcumin conjugate: A water soluble and effective cytotoxic agent against breast cancer cell lines. Anti-Cancer Agents in Medicinal Chemistry 2013, 13:1531-1539.
19. DeFelice S.L. The nutraceutical revolution: Its impact on food industry R&D. Trends in Food Science & Technology 1995, 6:59-61.
20. Deng C., Jiang Y., Cheng R., Meng F., Zhong Z. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects. Nano Today 2012, 7:467-480.
21. Díaz M.R., Vivas-Mejia P.E. Nanoparticles as drug delivery systems in cancer medicine: Emphasis on RNAi-containing nanoliposomes. Pharmaceuticals 2013, 6:1361-1380.
22. Ding Y., Wang Y., Opoku-Damoah Y., Wang C., Shen L., Yin L., et al. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy. Biomaterials 2015, 72:90-103.
23. Duraipandy N., Lakra R., Vinjimur S.K., Samanta D., Kiran M.S. Caging of plumbagin on silver nanoparticles imparts selectivity and sensitivity to plumbagin for targeted cancer cell apoptosis. Metallomics 2014, 6:2025-2033.
24. D'Ambrosio D.N., Clugston R.D., Blaner W.S. Vitamin a metabolism: An update. Nutrients 2011, 3:63-103.
25. El-Gogary R.I., Rubio N., Wang J.T., Al-Jamal W.T., Bourgognon M., Kafa H., et al. Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo. ACS Nano 2014, 8:1384-1401.
26. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. GLOBOCAN 2012 v1. 0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. 2013 2015, Accessed on 12.05.16. http://globocan.iarc.fr.
27. Fernández-García E., Carvajal-Lérida I., Jarén-Galán M., Garrido-Fernández J., Pérez-Gálvez A., Hornero-Méndez D. Carotenoids bioavailability from foods: From plant pigments to efficient biological activities. Food Research International 2012, 46:438-450.
28. Gonzalez-Vallinas M., Gonzalez-Castejon M., RodrÃguez-Casado A., de Molina A.R. Dietary phytochemicals in cancer prevention and therapy: A complementary approach with promising perspectives. Nutrition Reviews 2013, 71:585-599.
29. Gursoy R.N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & Pharmacotherapy 2004, 58:173-182.
30. Hoare T.R., Kohane D.S. Hydrogels in drug delivery: Progress and challenges. Polymer 2008, 49:1993-2007.
31. Huang P., Yang L.L., Wang C.Y., Chen J.P., Wang S.S., Wang S.J., et al. Preparation and characterization of folate targeting magnetic nanomedicine loaded with gambogenic acid. Journal of Nanoscience and Nanotechnology 2015, 15:4774-4783.
32. Hurst S., Loi C.-M., Brodfuehrer J., El-Kattan A. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology 2007, 3:469-489.
33. Izadi A., Manjili H.K., Ma'mani L., Moslemi E., Mashhadikhan M. Sulforaphane loaded PEGylated iron oxide-gold core shell nanoparticles: A promising delivery system for cancer therapy. American International Journal of Contemporary Scientific Research 2015, 2:84-94.
34. Jiang Y., Lu H., Dag A., Hart-Smith G., Stenzel M.H. Albumin-polymer conjugate nanoparticles and their interactions with prostate cancer cells in 2D and 3D culture: Comparison between PMMA and PCL. Journal of Materials Chemistry B 2016, 4:2017-2027.
35. Ji H., Tang J., Li M., Ren J., Zheng N., Wu L. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Delivery 2016, 23:459-470.
36. Kalra E.K. Nutraceutical-definition and introduction. Aaps Pharmsci 2003, 5:27-28.
37. Karthikeyan S., Hoti S.L., Prasad N.R. Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small cell lung cancer cells. Biomedicine & Pharmacotherapy 2015, 70:274-282.
38. Khan A.W., Kotta S., Ansari S.H., Sharma R.K., Ali J. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid naringenin: Design, characterization, in vitro and in vivo evaluation. Drug Delivery 2015, 22:552-561.
39. Khare V., Alam N., Saneja A., Dubey R.D., Gupta P.N. Targeted drug delivery systems for pancreatic cancer. Journal of Biomedical Nanotechnology 2014, 10:3462-3482.
40. Kim B.Y., Rutka J.T., Chan W.C. Nanomedicine. New England Journal of Medicine 2010, 363:2434-2443.
41. Kumar S.P., Birundha K., Kaveri K., Devi K.T. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells. International Journal of Biological Macromolecules 2015, 78:87-95.
42. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces 2010, 75:1-18.
43. Ladet S., David L., Domard A. Multi-membrane hydrogels. Nature 2008, 452:76-79.
44. Lao C.D., Ruffin M.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., et al. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 2006, 6:10.
45. Lee C.K., Ki S.H., Choi J.S. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: Possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharmaceutics & Drug Disposition 2011, 32:245-251.
46. Li Y., Ahmad A., Kong D., Bao B., Sarkar F.H. Recent progress on nutraceutical research in prostate cancer. Cancer and Metastasis Reviews 2014, 33:629-640.
47. Li M., Gao M., Fu Y., Chen C., Meng X., Fan A., et al. Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery. Colloids and Surfaces B Biointerfaces 2016, 140:11-18.
48. Li Y., Go V., Sarkar F.H. The role of nutraceuticals in pancreatic cancer prevention and therapy: Targeting cellular signaling, microRNAs, and epigenome. Pancreas 2015, 44:1-10.
49. Liu H., Gao M., Xu H., Guan X., Lv L., Deng S., et al. A promising emodin-loaded poly(lactic-co-glycolic acid)-d-alpha-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. Pharmaceutical Research 2016, 33:217-236.
50. Lo Y.-L., Sung K.-H., Chiu C.-C., Wang L.-F. Chemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene delivery. Molecular Pharmaceutics 2013, 10:664-676.
51. Luo Q., Lin T., Zhang C.Y., Zhu T., Wang L., Ji Z., et al. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake. International Journal of Pharmaceutics 2015, 493:30-39.
52. Luo C., Sun J., Sun B., He Z. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends in Pharmacological Sciences 2014, 35:556-566.
53. Madaan K., Kumar S., Poonia N., Lather V., Pandita D. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. Journal of Pharmacy & Bioallied Sciences 2014, 6(3):139-150.
54. Makarem N., Lin Y., Bandera E.V., Jacques P.F., Parekh N. Concordance with world Cancer research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991-2008). Cancer Causes & Control 2015, 26:277-286.
55. Mallath M.K., Taylor D.G., Badwe R.A., Rath G.K., Shanta V., Pramesh C., et al. The growing burden of cancer in India: Epidemiology and social context. Lancet Oncology 2014, 15:e205-e212.
56. Ma X., Moore Z.R., Huang G., Huang X., Boothman D.A., Gao J. Nanotechnology-enabled delivery of NQO1 bioactivatable drugs. Journal of Drug Targeting 2015, 23:672-680.
57. Manjili H.K., Sharafi A., Danafar H., Hosseini M., Ramazani A., Ghasemi M.H. Poly (caprolactone)-poly (ethylene glycol)-poly (caprolactone)(PCL-PEG-PCL) nanoparticles: A valuable and efficient system for in vitro and in vivo delivery of curcumin. RSC Advances 2016, 6:14403-14415.
58. Manju S., Sreenivasan K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. Journal of Colloid and Interface Science 2011, 359:318-325.
59. McClements D.J., Li F., Xiao H. The nutraceutical bioavailability classification scheme: Classifying nutraceuticals according to factors limiting their oral bioavailability. Annual Review of Food Science and Technology 2015, 6:299-327.
60. Moelants K.R., Lemmens L., Vandebroeck M., Van Buggenhout S., Van Loey A.M., Hendrickx M.E. Relation between particle size and carotenoid bioaccessibility in carrot-and tomato-derived suspensions. Journal of Agricultural and Food Chemistry 2012, 60:11995-12003.
61. Mohan A., Narayanan S., Balasubramanian G., Sethuraman S., Krishnan U.M. Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma. European Journal of Pharmaceutics and Biopharmaceutics 2016, 99:73-83.
62. Mukherjee S., Ghosh S., Das D.K., Chakraborty P., Choudhury S., Gupta P., et al. Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection-synthesis, characterization and in vitro evaluation. Journal of Nutritional Biochemistry 2015, 26:1283-1297.
63. Nagai H., Okazaki Y., Chew S.H., Misawa N., Yamashita Y., Akatsuka S., et al. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proceedings of the National Academy of Sciences 2011, 108:E1330-E1338.
64. Nair H.B., Sung B., Yadav V.R., Kannappan R., Chaturvedi M.M., Aggarwal B.B. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochemical Pharmacology 2010, 80:1833-1843.
65. Narayanan S., Mony U., Vijaykumar D.K., Koyakutty M., Paul-Prasanth B., Menon D. Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cells. Nanomedicine: Nanotechnology, Biology and Medicine 2015, 11:1399-1406.
66. Nehate C., Jain S., Saneja A., Khare V., Alam N., Dhar Dubey R., et al. Paclitaxel formulations: Challenges and novel delivery options. Current Drug Delivery 2014, 11:666-686.
67. Ng Y.J., Benson H.A., Brown D.H., Chen Y. Synthesis and characterization of novel copolymeric resveratrol conjugates. Journal of Chemistry 2015, 2015.
68. Ng W.K., Saiful Yazan L., Yap L.H., Wan Nor Hafiza W.A., How C.W., Abdullah R. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa). BioMed Research International 2015, 2015:263131.
69. Nkondjock A., Ghadirian P., Johnson K.C., Krewski D., Canadian Cancer Registries Epidemiology Research, G Dietary intake of lycopene is associated with reduced pancreatic cancer risk. The Journal of Nutrition 2005, 135:592-597.
70. Noriega-Luna B., Godínez L.A., Rodríguez F.J., Rodríguez A., Larrea G., Sosa-Ferreyra C., et al. Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection. Journal of Nanomaterials 2014, 2014:39.
71. Owen S.C., Chan D.P., Shoichet M.S. Polymeric micelle stability. Nano Today 2012, 7:53-65.
72. Pang X., Yang X., Zhai G. Polymer-drug conjugates: Recent progress on administration routes. Expert Opinion on Drug Delivery 2014, 11:1075-1086.
73. Parhi P., Mohanty C., Sahoo S.K. Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy. Drug Discovery Today 2012, 17:1044-1052.
74. Perche F., Torchilin V.P. Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. Journal of Drug Delivery 2013, 2013.
75. Pérez-Herrero E., Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European Journal of Pharmaceutics and Biopharmaceutics 2015, 93:52-79.
76. Piermartiri T., Pan H., Figueiredo T.H., Marini A.M. α-Linolenic acid, a nutraceutical with pleiotropic properties that targets endogenous neuroprotective pathways to protect against organophosphate nerve agent-induced neuropathology. Molecules 2015, 20:20355-20380.
77. Pillai J.J., Thulasidasan A., Anto R.J., Chithralekha D.N., Narayanan A., Kumar G. Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells. Journal of Nanobiotechnology 2014, 12:25.
78. Platt V.M., Szoka F.C. Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Molecular Pharmaceutics 2008, 5:474-486.
79. Porter C.J., Pouton C.W., Cuine J.F., Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Advanced Drug Delivery Reviews 2008, 60:673-691.
80. Porter C.J., Trevaskis N.L., Charman W.N. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nature Reviews Drug Discovery 2007, 6:231-248.
81. Pouton C.W. Formulation of self-emulsifying drug delivery systems. Advanced Drug Delivery Reviews 1997, 25:47-58.
82. Rajendran I., Dhandapani H., Anantanarayanan R., Rajaram R. Apigenin mediated gold nanoparticle synthesis and their anti-cancer effect on human epidermoid carcinoma (A431) cells. RSC Advances 2015, 5:51055-51066.
83. Ramalingam P., Ko Y.T. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Colloids and Surfaces B Biointerfaces 2016, 139:52-61.
84. Saneja A., Dhar Dubey R., Alam N., Khare V., Gupta P.N. Co-formulation of P-glycoprotein substrate and inhibitor in nanocarriers: An emerging strategy for cancer chemotherapy. Current Cancer Drug Targets 2014, 14:419-433.
85. Saneja A., Khare V., Alam N., Dubey R.D., Gupta P.N. Advances in P-glycoprotein-based approaches for delivering anticancer drugs: Pharmacokinetic perspective and clinical relevance. Expert Opinion on Drug Delivery 2014, 11:121-138.
86. Saneja A., Nehate C., Alam N., Gupta P.N. Recent advances in chitosan-based nanomedicines for cancer chemotherapy. Chitin and chitosan for regenerative medicine 2016, 229-259. Springer.
87. Santos H.A., Bimbo L.M., Peltonen L., Hirvonen J. Inorganic nanoparticles in targeted drug delivery and imaging. Targeted drug delivery: Concepts and design 2015, 571-613. Springer.
88. Sarkar F.H., Li Y., Wang Z., Kong D. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer and Metastasis Reviews 2010, 29:383-394.
89. Sercombe L., Veerati T., Moheimani F., Wu S.Y., Sood A.K., Hua S. Advances and challenges of liposome assisted drug delivery. Frontiers in Pharmacology 2015, 6.
90. Shafiei S.S., Solati-Hashjin M., Samadikuchaksaraei A., Kalantarinejad R., Asadi-Eydivand M., Osman N.A.A. Epigallocatechin gallate/layered double hydroxide nanohybrids: preparation, characterization, and in vitro anti-tumor study. PloS One 2015, 10:e0136530.
91. Shao A., Chen G., Jiang N., Li Y., Zhang X., Wen L., et al. Development and evaluation of self-microemulsifying liquid and granule formulations of Brucea javanica oil. Archives of Pharmacal Research 2013, 36:993-1003.
92. Siddiqui I.A., Adhami V.M., Bharali D.J., Hafeez B.B., Asim M., Khwaja S.I., et al. Introducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 2009, 69:1712-1716.
93. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA: a Cancer Journal for Clinicians 2016, 66:7-30.
94. Soni P., Kaur J., Tikoo K. Dual drug-loaded paclitaxel-thymoquinone nanoparticles for effective breast cancer therapy. Journal of Nanoparticle Research 2015, 17:1-12.
95. Soo E., Thakur S., Qu Z., Jambhrunkar S., Parekh H.S., Popat A. Enhancing delivery and cytotoxicity of resveratrol through a dual nanoencapsulation approach. J Colloids and Interface Science 2016, 462:368-374.
96. Suksiriworapong J., Phoca K., Ngamsom S., Sripha K., Moongkarndi P., Junyaprasert V.B. Comparison of poly(epsilon-caprolactone) chain lengths of poly(epsilon-caprolactone)-co-d-alpha-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 2016, 101:15-24.
97. Sutradhar K.B., Amin M.L. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnology 2014, 2014.
98. Talelli M., Barz M., Rijcken C.J., Kiessling F., Hennink W.E., Lammers T. Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation. Nano Today 2015, 10:93-117.
99. Teong B., Lin C.-Y., Chang S.-J., Niu G.C.-C., Yao C.-H., Chen I.-F., et al. Enhanced anti-cancer activity by curcumin-loaded hydrogel nanoparticle derived aggregates on A549 lung adenocarcinoma cells. Journal of Materials Science: Materials in Medicine 2015, 26:1-15.
100. Thanki K., Gangwal R.P., Sangamwar A.T., Jain S. Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Controlled Release 2013, 170:15-40.
101. Trottier G., Boström P.J., Lawrentschuk N., Fleshner N.E. Nutraceuticals and prostate cancer prevention: A current review. Nature Reviews Urology 2010, 7:21-30.
102. Vecchione R., Quagliariello V., Calabria D., Calcagno V., De Luca E., Iaffaioli R.V., et al. Curcumin bioavailability from oil in water nano-emulsions: In vitro and in vivo study on the dimensional, compositional and interactional dependence. Journal of Controlled Release 2016, 10.1016/j.jconrel.2016.05.004.
103. Wang Z., Chen C., Zhang Q., Gao M., Zhang J., Kong D., et al. Tuning the architecture of polymeric conjugate to mediate intracellular delivery of pleiotropic curcumin. European Journal of Pharmaceutics and Biopharmaceutics 2015, 90:53-62.
104. Wang J., Guleria S., Koffas M.A., Yan Y. Microbial production of value-added nutraceuticals. Current Opinion in Biotechnology 2016, 37:97-104.
105. Wang L., Luo Q., Lin T., Li R., Zhu T., Zhou K., et al. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Development and Industrial Pharmacy 2015, 41:1204-1212.
106. Wang C., Shan Y., Yang J., Xu X., Zhuang B., Fan Y., et al. Inhibition of cancer angiogenesis using triptolide nanoparticles. Journal of Biomedical Nanotechnology 2015, 11:805-815.
107. Wang L., Wang W., Rui Z., Zhou D. The effective combination therapy against human osteosarcoma: Doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Drug Delivery 2016, 1-33.
108. Wang L., Xu X., Zhang Y., Zhang Y., Zhu Y., Shi J., et al. Encapsulation of curcumin within poly (amidoamine) dendrimers for delivery to cancer cells. Journal of Materials Science: Materials in Medicine 2013, 24:2137-2144.
109. Weber S., Zimmer A., Pardeike J. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2014, 86:7-22.
110. Wu B., Liang Y., Tan Y., Xie C., Shen J., Zhang M., et al. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer. Materials Science and Engineering C: Materials for Biological Applications 2016, 59:792-800.
111. Wu Y., Wang Z., Liu G., Zeng X., Wang X., Gao Y., et al. Novel simvastatin-loaded nanoparticles based on cholic acid-core star-shaped PLGA for breast cancer treatment. Journal of Biomedical Nanotechnology 2015, 11:1247-1260.
112. Xu P., Wang R., Li J., Ouyang J., Chen B. PEG-PLGA-PLL nanoparticles in combination with gambogic acid for reversing multidrug resistance of K562/A02 cells to daunorubicin. RSC Advances 2015, 5:61051-61059.
113. Yadollahi R., Vasilev K., Simovic S. Nanosuspension technologies for delivery of poorly soluble drugs. Journal of Nanomaterials 2015, 2015.
114. Yallapu M.M., Ebeling M.C., Khan S., Sundram V., Chauhan N., Gupta B.K., et al. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Molecular Cancer Therapeutics 2013, 12:1471-1480.
115. Zaman M.S., Chauhan N., Yallapu M.M., Gara R.K., Maher D.M., Kumari S., et al. Curcumin nanoformulation for cervical cancer treatment. Science Report 2016, 6:20051.
116. Zhang Y., Chen T., Yuan P., Tian R., Hu W., Tang Y., et al. Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells. Carbohydrate Polymers 2015, 133:31-38.
117. Zhang H., Zheng D., Ding J., Xu H., Li X., Sun W. Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (epsilon-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo. International Journalof Nanomedicine 2015, 10:1909-1920.
118. Zhao J., Lee P., Wallace M.J., Melancon M.P. Gold nanoparticles in cancer therapy: Efficacy, biodistribution, and toxicity. Current Pharmaceutical Design 2015, 21:4240-4251.
119. Zhao T., Liu Y., Gao Z., Gao D., Li N., Bian Y., et al. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes. Materials Science and Engineering C: Materials for Biological Applications 2015, 53:196-203.
120. Zhao J., Liu J., Wei T., Ma X., Cheng Q., Huo S., et al. Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo. Nanoscale 2016, 8(9):5126-5138.
121. Zhong Y., Meng F., Deng C., Zhong Z. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules 2014, 15:1955-1969.
122. Zhou L., Duan X., Zeng S., Men K., Zhang X., Yang L., et al. Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis. International Journalof Nanomedicine 2015, 10:5205.
123. Zhou Y., Yu Q., Qin X., Bhavsar D., Yang L., Chen Q., et al. Improving the anticancer efficacy of laminin receptor-specific therapeutic Ruthenium nanoparticles (RuBB-Loaded EGCG-RuNPs) via ROS-dependent apoptosis in SMMC-7721 cells. ACS Applied Material Interfaces 2015, 10.1021/acsami.5b022612015.
124. Zou L.-q., Peng S.-f., Liu W., Gan L., Liu W.-l., Liang R.-h., et al. Improved in vitro digestion stability of (-)-epigallocatechin gallate through nanoliposome encapsulation. Food Research International 2014, 64:492-499.